aponvie - aprepitant emulsion
(Aprepitant)Heron Therapeutics, Inc.
Usage: Aponvie is indicated for the prevention of postoperative nausea and vomiting (PONV) in adults. It has not been studied for treatment of established nausea and vomiting.
Cytochrome P450 3A4 Inducers [MoA] class drugs
165 results
aprepitant - aprepitant capsule
(Aprepitant)Sandoz Incaprepitant - aprepitant capsule
(Aprepitant)Glenmark Pharmaceuticals Inc., Usaaprepitant - aprepitant capsule
(Aprepitant)Torrent Pharmaceuticals Limitedaprepitant - aprepitant capsule
(Aprepitant)Bluepoint Laboratoriesaprepitant - aprepitant capsule
(Aprepitant)Golden State Medical Supply, Inc.augtyro - repotrectinib capsule
(Repotrectinib)E.R. Squibb & Sons, L.L.C.Usage: Augtyro treats adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer. It also treats adults and patients aged 12+ with locally advanced or metastatic NTRK gene fusion-positive solid tumors that have progressed on prior treatment or have no satisfactory alternative therapy.balversa - erdafitinib tablet, film coated
(Erdafitinib)Janssen Products LpUsage: BALVERSA treats adults with locally advanced or metastatic urothelial carcinoma with susceptible FGFR3 genetic alterations whose disease progressed after at least one prior systemic therapy. Patient selection requires an FDA-approved companion diagnostic. Not recommended for patients eligible for PD-1/PD-L1 inhibitor therapy who have not yet received it.carbamazepine
(Carbamazepine)Ascend Laboratories, Llccarbamazepine
(Carbamazepine)Ani Pharmaceuticals, Inc.